TY - JOUR
T1 - Improving PCI Outcomes Using Postprocedural Physiology and Intravascular Imaging
AU - van Zandvoort, Laurens J.C.
AU - Ali, Ziad
AU - Kern, Morton
AU - van Mieghem, Nicolas M.
AU - Mintz, Gary S.
AU - Daemen, Joost
N1 - Funding Information:
Dr van Zandvoort has received institutional research support from ACIST Medical, Pie Medical Imaging, and REVA Medical. Dr Ali has received grants from Abbott Vascular and Cardiovascular Systems; personal fees from Amgen, AstraZeneca, and Boston Scientific; and holds equity in Shockwave Medical. Dr Kern has received consulting fees from Abbott, ACIST Medical, Boston Scientific, OpSens Medical, and Philips. Dr Mintz has received honoraria from Boston Scientific, Philips/Volcano, Medtronic, and Abiomed. Dr van Mieghem has received institutional research grants from Abbott, Boston Scientific, Medtronic, PulseCath BV, Abiomed, Daiichi-Sankyo, and Edwards Lifesciences. Dr Daemen has received institutional grant and research support from AstraZeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Pie Medical Imaging, and ReCor Medical.
Publisher Copyright:
© 2021
PY - 2021/11/22
Y1 - 2021/11/22
N2 - Although clinical outcomes after percutaneous coronary intervention (PCI) are improving, the long-term risk for target vessel failure remains concerning. Although the application of intravascular imaging and physiological indexes significantly improves outcomes, their routine use in practice remains limited. Nevertheless, merely using these modalities is not enough, and to truly improve patient outcomes, optimal intravascular dimensions with minimal vascular injury should be targeted. When assessing post-PCI results using either type of physiological or imaging technology, a broad spectrum of stent- and vessel-related anomalies can be expected. As not all of these issues warrant treatment, a profound knowledge of what to expect and how to recognize and when to treat these intraluminal problems is needed. Additionally, promising new modalities such as angiography-derived coronary physiology and hybrid imaging catheters are becoming available. The authors provide an overview of the currently available tools and techniques to define suboptimal PCI and when to apply these technologies to improve outcomes.
AB - Although clinical outcomes after percutaneous coronary intervention (PCI) are improving, the long-term risk for target vessel failure remains concerning. Although the application of intravascular imaging and physiological indexes significantly improves outcomes, their routine use in practice remains limited. Nevertheless, merely using these modalities is not enough, and to truly improve patient outcomes, optimal intravascular dimensions with minimal vascular injury should be targeted. When assessing post-PCI results using either type of physiological or imaging technology, a broad spectrum of stent- and vessel-related anomalies can be expected. As not all of these issues warrant treatment, a profound knowledge of what to expect and how to recognize and when to treat these intraluminal problems is needed. Additionally, promising new modalities such as angiography-derived coronary physiology and hybrid imaging catheters are becoming available. The authors provide an overview of the currently available tools and techniques to define suboptimal PCI and when to apply these technologies to improve outcomes.
KW - FFR
KW - IVUS
KW - OCT
KW - dPR
KW - iFR
KW - intravascular imaging
KW - physiology
KW - post-PCI
KW - target vessel failure
UR - http://www.scopus.com/inward/record.url?scp=85118535740&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2021.08.069
DO - 10.1016/j.jcin.2021.08.069
M3 - Review article
C2 - 34794649
AN - SCOPUS:85118535740
SN - 1936-8798
VL - 14
SP - 2415
EP - 2430
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 22
ER -